The Monaco Initiative for Concussion in Motorsport Pilots

The Monaco Initiative for Concussion in Motorsport Pilots: Brain Exploration in Retired Motorsport Pilots

The study aims:

  • to observe a population particularly exposed by the past to brain trauma and concussion: Motorsport Pilots who are retired from a professional practice of motor sport;
  • to report results of their neuro-cognitive evaluations,
  • to determine if specific profiles emerge.
  • to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.
  • to evaluate the contribution of the various examinations performed as part of a concussion assessment in routine care (eye-tracking, brain imaging, Neuropsychological Assessment).

Study Overview

Detailed Description

The Memory Center of the Rainier III Center and The Department of Nuclear Medicine of the Princess Grace Hospital are particularly aware of evaluation, management and monitoring of patients who have suffered brain trauma, or concussions, and the study of possible long-term consequences.

They regularly receive patients, referred by neurologists or spontaneously coming for consultation, for whom the carrying out of a complete in-depth evaluation is recommended, because of their medical history and their personal history.

In partnership with the "Fédération Internationale de l'Automobile" (FIA) and the "Automobile Club of Monaco" (ACM), the Princess Grace Hospital team hopes ultimately to set up a screening campaign for traumatic brain injuries among a particularly exposed population: motorsports people.

In this context, inspired by the work carried out by the Cambridge University team (the Rescue Racer Study) and the FIA recommendations, the Sponsor wishes to carry out an observational study with retired motor sportspeople.

The objectives are to study a population particularly exposed by the past to brain trauma and concussion (who is retired from a professional practice of motor sport), to report results of their neuro-cognitive evaluations, and to determine if specific profiles emerge, to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Monaco, Monaco, 98000
        • Princess Grace Hospital / Department of Nuclear Medicine / Memory Center of the Rainier III Clinical Gerontology Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Retired motorsport pilots coming to the CHPG for a memory assessment or concussion assessment, meeting the study's inclusion criteria, and volunteering to participate.

All assessments and examinations are carried out in routine care, so study essential data will be collected from the patient's medical file (source file): Demographic data, Medical history, Sport practice History of sports, Results of neurological and neuropsychological assessments, Eye-tracking results, MRI results, PET-FDG results.

Description

  • Men or women.
  • Aged 18 years and older.
  • Retired motor sport pilot (Formula 1 or rally).
  • Expressing a cognitive, memory, somatic, emotional complaint, sleep disorders or a concern following the practice of Motorsport, that motivate carrying out of a memory assessment or a concussion assessment in routine care.
  • Who are willing to participate in the study and give their written informed consent.
  • Covered by a health insurance system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Retired Motorsport Pilots
Concussion assessment
Essential data for this study are those collected during the concussion assessment, carried out as part of routine care at Princess Grace Hospital (medical background; history of sports practice and history of concussions; data extracted from clinical and neuropsychological evaluations, from imaging exams (MRI and PET-Scan) and from eye-tracking evaluation).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients description
Time Frame: Baseline
Describe the profile of included patients
Baseline
Medical history of concussion
Time Frame: Baseline
Describe the Medical history of concussion of included patients
Baseline
Presence of Post Concussive Symptoms
Time Frame: Baseline
Assessed by the Symptoms Scale of the Sport Concussion Assessment Tool (SCAT), composed of 22 post concussive symptom items graded on a scale from 0 (no symptoms) to 6 (severe symptoms), summed to form a symptom severity score (range 0-132).
Baseline
Neurological evaluation
Time Frame: Baseline
Assessed by the Neurological exam part of the Sport Concussion Assessment Tool (SCAT), composed of 5 questions.
Baseline
Postural stability
Time Frame: Baseline
Assessed by Balance Error Scoring System (BESS). Score of 0-60 (lower scores indicate better balance and less errors)
Baseline
MRI scan
Time Frame: Baseline
MRI data are described according to their nature (lesion / atrophy / sequel / signal anomaly), and classified as present or absent.
Baseline
PET/CT scan - Visual analysis
Time Frame: Baseline
Description of possible hypometabolic or hypermetabolic areas of the cerebral cortex on the PET / CT images of the subject.
Baseline
PET/CT scan - Parametric analysis
Time Frame: Baseline
The uptake values of [18F]-2-fluoro-2-deoxy-D-glucose (18-FDG) (average uptake and standard deviation) of several target regions of the subject's cerebral cortex will be entered in comparison with an age-matched database developed in the Scenium software from Siemens Medical Solutions USA® (software version VB30A)
Baseline
PET/CT scan - other description
Time Frame: Baseline
Description of any abnormalities found on non-opacified CT slices.
Baseline
Global cognitive performance
Time Frame: Baseline
MONTREAL COGNITIVE ASSESSMENT (MOCA) is used to evaluate Global cognitive performance. MOCA is a 30-question general cognitive function assessment. The maximum score is 30. Performance of each participant is compared to their reference sample (depending on age, sex and level study).
Baseline
Episodic memory performance
Time Frame: Baseline
The Grober and Buschke Free and Cued recall (16 items) or the Selective Reminding Test are used to evaluate Episodic memory. Performances of each participant are compared to their reference sample (depending on age, sex and level study).
Baseline
Executive performance - Trail Making Test A&B
Time Frame: Baseline
Trail Making Test (T.M.T) A&B is used to evaluate executive performance. The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper, in the shortest time possible without lifting the pen from the paper. Time performances of each participant are compared to their reference sample.
Baseline
Executive performance - Stroop test
Time Frame: Baseline
Stroop test (GREFFEX) is used to evaluate executive performance and more specifically inhibition. The time to complete each condition (in seconds) is recorded, as well as the number of uncorrected and corrected errors. Stroop task performances of each participant are compared to their reference sample.
Baseline
Executive performance - B.R.E.F.
Time Frame: Baseline
The "Batterie rapide d'évaluation frontale" (B.R.E.F.), or Frontal Assessment Battery at Bedside (F.A.B.), is used to determine the presence or not of a cognitive and behavioral dysexecution syndrom. The maximum score is 18. Performances of each participant are compared to their reference sample.
Baseline
Executive performance - The Modified Card Sorting Test of Nelson (MCST)
Time Frame: Baseline
The Modified Card Sorting Test of Nelson (MCST) is used to evaluate executive function in patients with focal, traumatic and degenerative brain diseases. Performance on the MCST is scored by computing the number of categories achieved by a participant, and the number of perseverative errors. Performance of each participant are compared to their reference sample.
Baseline
Verbal fluency
Time Frame: Baseline
Verbal fluency test is a short test of verbal functioning. It consists of two tasks: category fluency and letter fluency. Participant is given 1 minute to produce as many unique words as possible within a semantic category (category fluency) or starting with a given letter (letter fluency). The participant's score in each task is the number of unique correct words. Performances of each participant are compared to their reference sample.
Baseline
Visuospatial/constructional ability
Time Frame: Baseline
Rey-complex copy figure test is used to evaluate visuospatial/constructional abilities. Performance of each participant is compared to their reference sample.
Baseline
Social cognition and Emotional assessment
Time Frame: Baseline
The Mini-sea is used to evaluate Social cognition. Evaluation criteria: Scores to Ekman Faces task (1976): total score / 35 and sub-scores / 5. Performances of each participant are compared to their reference sample.
Baseline
Selective and sustained attention
Time Frame: Baseline
The d2 Test of Attention is a cancellation test of attention and concentration that measures selective and sustained attention. Participant cross out any letter "d" with two marks around above it or below it in any order. The surrounding distractors are usually similar to the target stimulus, for example a "p" with two marks or a "d" with one or three marks (Ability to concentrate, Processing speed, Percentage of errors). The quotation provides values for the three main indices. Performances of each participant are compared to their reference sample.
Baseline
Storage and handling of information, short term and working memory skill
Time Frame: Baseline
The Digit span and spatial span tasks (Empans) assess the storage and handling of information, short term and working memory skill. Participant reads a sequence of numbers and is asked to repeat the same sequence back to the examiner in order (forward span) or in reverse order (backward span). As well for spatial span task. Four scores are obtained (forward and backward verbal scores, forward and backward visuospatial scores). Performances of each participant are compared to their reference sample.
Baseline
Working memory
Time Frame: Baseline
Baddeley's dual task assess the ability to coordinate two tasks simultaneously divided attention ability. The score of each participant are compared to their reference sample.
Baseline
A sustained attention and working memory test
Time Frame: Baseline
PASAT (Paced Auditory Serial Addition Test) is a sustained attention and working memory test. The results are expressed as a score of 60 points. Performances of each participant are compared to their reference sample.
Baseline
Language
Time Frame: Baseline
The "Dénomination d'Objet 80" (DO 80), is an image naming task in order to assess language and visual gnosias.
Baseline
Oculomotor paradigms raw performance - Horizontal saccades Latency
Time Frame: Baseline

This concerns saccades Latency (in ms) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

Baseline
Oculomotor paradigms raw performance - Horizontal saccades Main velocity
Time Frame: Baseline

This concerns saccades Main velocity (in °/sec) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

Baseline
Oculomotor paradigms raw performance - Horizontal saccades Gain.
Time Frame: Baseline

This concerns saccades Gain (gaze accuracy) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 Standard Deviation (SD) compared to their reference sample.

Baseline
Oculomotor paradigms raw performance - Vertical saccades Latency
Time Frame: Baseline

This concerns saccades Latency (in ms) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

Baseline
Oculomotor paradigms raw performance - Vertical saccades Main Velocity
Time Frame: Baseline

This concerns saccades Main velocity (in °/sec) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

Baseline
Oculomotor paradigms raw performance - Vertical saccades Gain
Time Frame: Baseline

This concerns saccades Gain (gaze accuracy) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device.

For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.

Baseline
Inhibition capacity
Time Frame: Baseline
Measure of inhibition capacity performance during an "antisaccades" paradigm. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: percentage of errors. For each subject value were judged abnormal if they differed by >1.65 SD compared to their reference sample.
Baseline
Internuclear ophthalmoplegia (INO) detection
Time Frame: Baseline
Highlight presence/absence of INO. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: INO is present if calculated ratio of abducting to adducting eye movement (both mean and peak velocity) is >1.
Baseline
Fixations impairments detection
Time Frame: Baseline
Highlight presence/absence of Fixations impairments. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence/frequency of square wave-jerks, nystagmus, flutters.
Baseline
Impairment of smooth pursuit
Time Frame: Baseline
Highlight Impairment of horizontal and vertical smooth pursuit. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence of saccade and perturbation.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benoit PAULMIER, Department of Nuclear Medicine, Princess Grace Hospital, Monaco.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 5, 2021

Primary Completion (Actual)

August 5, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

January 25, 2021

First Posted (Actual)

January 29, 2021

Study Record Updates

Last Update Posted (Actual)

October 18, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Injuries

Clinical Trials on Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.

3
Subscribe